文献速递心血管CT

CT测量的左心外膜脂肪组织衰减与心房颤动的相关性:系统评价与Meta分析

The Relationship between Left Epicardial Adipose Tissue Attenuation at CT and Atrial Fibrillation: A Systematic Review and Meta-Analyses.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

该系统评价与Meta分析纳入16篇文章、4175例患者,评估CT测量的心外膜脂肪组织衰减与心房颤动患病率、类型及消融后复发的关联。总体未发现显著关联,但在管电压设置一致或校正的研究中,较高的心外膜脂肪组织衰减与较高的心房颤动患病率中度相关,与较低的消融后复发风险轻度相关,心房颤动类型仍无关联。

要点

  • 总体分析中CT心外膜脂肪组织衰减与心房颤动患病率、类型及消融后复发均无显著关联。
  • 管电压设置一致或校正的研究中,较高心外膜脂肪组织衰减与较高心房颤动患病率中度相关(SMD 0.52)。
  • 同一亚组中,较高心外膜脂肪组织衰减与较低的消融后复发风险轻度相关(SMD -0.15)。

核心结论

  • 在使用一致或校正管电压设置的研究中,较高的CT心外膜脂肪组织衰减与较高的心房颤动患病率及较低的消融后复发风险相关,凸显了需要方法学统一的研究来明确心外膜脂肪组织衰减在心房颤动中的预后价值。

研究设计与样本

  • 系统评价与Meta分析,检索Medline、Embase和Cochrane数据库截至2023年7月发表的评估CT来源心外膜脂肪组织衰减与心房颤动患病率、类型或消融后复发关联的研究,共纳入16篇文章、4175例患者,效应量以标准化均数差(SMD)表示。

诊断标准与关键数值

  • 总体分析:心外膜脂肪组织衰减与心房颤动患病率无显著关联(SMD 0.33,95%CI:-0.14,0.79;P=0.17;I²=90%),与心房颤动类型无显著关联(SMD -0.09,95%CI:-0.37,0.20;P=0.56;I²=77%),与心房颤动复发无显著关联(SMD -0.01,95%CI:-0.21,0.19;P=0.92;I²=84%);管电压设置一致或校正的研究中,较高心外膜脂肪组织衰减与较高心房颤动患病率中度相关(SMD 0.52,95%CI:0.07,0.97;P=0.02;I²=81%),与较低的消融后复发风险轻度相关(SMD -0.15,95%CI:-0.27,-0.04;P=0.01;I²=0%),与心房颤动类型仍无关联。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 总体分析中心房颤动患病率分析异质性I²=90%。
  • 总体分析中心房颤动类型分析异质性I²=77%。
  • 总体分析中心房颤动复发分析异质性I²=84%。
  • 管电压设置一致或校正的研究中心房颤动患病率分析异质性I²=81%。
  • 作者强调需要方法学统一的研究来明确心外膜脂肪组织衰减在心房颤动中的预后价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To perform a systematic review and meta-analysis to assess the association between epicardial adipose tissue (EAT) attenuation on CT images and atrial fibrillation (AF). Materials and Methods The Medline, Embase, and Cochrane databases were systematically searched to identify studies published up to July 2023 that assessed the association between CT-derived EAT attenuation and AF prevalence, type, or recurrence after ablation. Meta-analyses were performed to assess the relationship between EAT attenuation and AF outcomes, expressed as the standardized mean difference (SMD). Effect sizes were considered small/modest (around 0.2), moderate (around 0.5), or large (around 0.8). Sensitivity analyses were performed based on voltage selection. Results Sixteen articles, encompassing 4175 patients, were included. Overall, CT EAT attenuation was not associated with AF prevalence (SMD, 0.33 [95% CI: -0.14, 0.79]; P = .17; I2 = 90%), AF type (SMD, -0.09 [95% CI: -0.37, 0.20]; P = .56; I2 = 77%), or AF recurrence (SMD, -0.01 [95% CI: -0.21, 0.19]; P = .92; I2 = 84%). However, in studies using consistent or corrected tube voltage settings, higher CT EAT attenuation was moderately associated with higher AF prevalence (SMD, 0.52 [95% CI: 0.07, 0.97]; P = .02; I2 = 81%) and modestly associated with a lower risk of AF recurrence after ablation (SMD, -0.15 [95% CI: -0.27, -0.04]; P = .01; I2 = 0%); EAT attenuation remained unassociated with AF type. Conclusion Higher CT EAT attenuation was associated with higher AF prevalence and lower risk of AF recurrence after ablation in studies using consistent or corrected tube voltage settings, highlighting the need for methodologically uniform studies to clarify the prognostic value of EAT attenuation in AF. Keywords: Epicardial Fat, CT, Atrial Fibrillation Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Meulendijks ER, Zappala P, de Vries TAC, et al. The Relationship between Left Epicardial Adipose Tissue Attenuation at CT and Atrial Fibrillation: A Systematic Review and Meta-Analyses. Radiol Cardiothorac Imaging. 2025. PMID: 41410573. doi:10.1148/ryct.250015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。